Unbound MEDLINE

The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A. [J Thromb Haemost] Journal article

 
TitleThe risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.
Author(s)Martinelli I, Battaglioli T, De Stefano V, Tormene D, Valdrè L, Grandone E, Tosetto A, Mannucci PM, on behalf of the GIT (Gruppo Italiano Trombofilia) 
InstitutionA. Bianchi Bonomi Haemophilia and Thrombosis Center, Department of Internal Medicine and Medical Specialties, University of Milan and IRCCS Ospedale Maggiore Policlinico, Mangiagalli and Regina Elena Foundation, Milan, Italy.
SourceJ Thromb Haemost 2007 Dec 19.
AbstractBackground: The risk of venous thromboembolism (VTE) during pregnancy in double heterozygous carriers of factor V Leiden and prothrombin G20210A is not established. Hence, whether or not these women deserve antithrombotic prophylaxis when pregnant is unknown. Patients and
Methods: In the frame of a multicenter family study, 52 double heterozygous carriers of factor V Leiden and prothrombin G20210A who had remained pregnant at least once before knowledge of thrombophilia were retrospectively investigated with respect to the occurrence of first VTE during pregnancy and puerperium. They were compared to 104 heterozygous carriers of factor V Leiden, 104 of prothrombin G20210A and 104 women without thrombophilia.
Results: Double heterozygotes were similar to single heterozygous carriers and non-carriers for the age at first pregnancy, age at testing and rate of full term pregnancies. No VTE during pregnancy was observed in the 4 groups of women, whereas in the puerperium it occurred in 2 double carriers (1.8% of pregnancies, 95%CI 0.5-6.3), 3 single factor V Leiden carriers (1.5%, 0.5-4.3), 2 single prothrombin G20210A carriers (1%, 0.2-3.6) and 1 non-carrier (0.4%, 0-2.5).
Conclusions: The risk of first VTE during pregnancy and puerperium in double heterozygous carriers of factor V Leiden and prothrombin G20210A is low and similar to that of single carriers. As for single heterozygotes, antithrombotic prophylaxis in asymptomatic double heterozygous carriers appears to be justified only in puerperium.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID18182035
  
Advertise on this site.